Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the following late-breaking poster presentation will be made at the 12th International Congress on Targeted Anticancer Therapies in Washington, D.C.:
“Hsp90 Inhibitor Drug Conjugates (HDCs): A Novel Drug Delivery Platform Technology”
Help employers find you! Check out all the jobs and post your resume.
